- Home
- BEDU vs MAIA Comparison
BEDU vs MAIA Comparison
Compare BEDU & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- MAIA
- Stock Information
- Founded
- BEDU 1994
- MAIA 2018
- Country
- BEDU United Kingdom
- MAIA United States
- Employees
- BEDU N/A
- MAIA N/A
- Industry
- BEDU Other Consumer Services
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- MAIA Health Care
- Exchange
- BEDU Nasdaq
- MAIA Nasdaq
- Market Cap
- BEDU 44.9M
- MAIA 44.8M
- IPO Year
- BEDU 2017
- MAIA 2022
- Fundamental
- Price
- BEDU $1.48
- MAIA $1.55
- Analyst Decision
- BEDU
- MAIA
- Analyst Count
- BEDU 0
- MAIA 0
- Target Price
- BEDU N/A
- MAIA N/A
- AVG Volume (30 Days)
- BEDU 24.4K
- MAIA 75.2K
- Earning Date
- BEDU 04-29-2025
- MAIA 05-13-2025
- Dividend Yield
- BEDU N/A
- MAIA N/A
- EPS Growth
- BEDU N/A
- MAIA N/A
- EPS
- BEDU N/A
- MAIA N/A
- Revenue
- BEDU $231,461,038.00
- MAIA N/A
- Revenue This Year
- BEDU N/A
- MAIA N/A
- Revenue Next Year
- BEDU N/A
- MAIA N/A
- P/E Ratio
- BEDU N/A
- MAIA N/A
- Revenue Growth
- BEDU N/A
- MAIA N/A
- 52 Week Low
- BEDU $1.35
- MAIA $1.40
- 52 Week High
- BEDU $2.42
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- BEDU 40.48
- MAIA 46.60
- Support Level
- BEDU $1.50
- MAIA $1.41
- Resistance Level
- BEDU $1.78
- MAIA $1.61
- Average True Range (ATR)
- BEDU 0.22
- MAIA 0.11
- MACD
- BEDU -0.03
- MAIA 0.01
- Stochastic Oscillator
- BEDU 5.38
- MAIA 62.50
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.